Abstract
Liver cancer is a prevalent form of cancer that impacts millions of people globally and contributes significantly to cancer-related deaths. Biomarkers, identifiable indicators of biological activities in the bloodstream, have emerged as a viable technique for enhancing the diagnosis and prediction of liver cancer. This chapter provides a comprehensive analysis of the current status of biomarker research in liver cancer, along with the potential implications for future advancements in the detection and treatment of liver cancer. This chapter also emphasizes the ongoing difficulties when utilizing biomarkers in therapeutic contexts.
| Original language | English |
|---|---|
| Title of host publication | Biomarker Landscape in Cancer Research |
| Publisher | Elsevier |
| Pages | 1-23 |
| Number of pages | 23 |
| ISBN (Electronic) | 9780443339028 |
| ISBN (Print) | 9780443339035 |
| DOIs | |
| Publication status | Published - 1 Jan 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alpha-fetoprotein
- Biomarker
- Chemiluminescent
- Genomic
- Hepatitis
- Immunoassay
- Liver cancer
- Osteopontin
Fingerprint
Dive into the research topics of 'Liver cancer: Biomarker landscape'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver